BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36538359)

  • 1. Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with Morphine.
    Simons P; van der Schrier R; van Lemmen M; Jansen S; Kuijpers KWK; van Velzen M; Sarton E; Nicklas T; Michalsky C; Demitrack MA; Fossler M; Olofsen E; Niesters M; Dahan A
    Anesthesiology; 2023 Mar; 138(3):249-263. PubMed ID: 36538359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine.
    Dahan A; van Dam CJ; Niesters M; van Velzen M; Fossler MJ; Demitrack MA; Olofsen E
    Anesthesiology; 2020 Sep; 133(3):559-568. PubMed ID: 32788558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive Effect of Biased µ-Opioid Receptor Agonist Oliceridine, a Utility Function Analysis and Comparison with Morphine.
    Moss L; Hijma H; Demitrack M; Kim J; Groeneveld GJ; van Velzen M; Niesters M; Olofsen E; Dahan A
    Anesthesiology; 2023 Dec; 139(6):746-756. PubMed ID: 37656771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.
    Bergese S; Berkowitz R; Rider P; Ladouceur M; Griffith S; Segura Vasi A; Cochrane K; Wase L; Demitrack MA; Habib AS
    Pain Res Manag; 2020; 2020():7492865. PubMed ID: 33163127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.
    Ayad S; Demitrack MA; Burt DA; Michalsky C; Wase L; Fossler MJ; Khanna AK
    Clin Drug Investig; 2020 Aug; 40(8):755-764. PubMed ID: 32583295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model.
    Fossler MJ; Sadler BM; Farrell C; Burt DA; Pitsiu M; Skobieranda F; Soergel DG
    J Clin Pharmacol; 2018 Jun; 58(6):750-761. PubMed ID: 29412458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
    Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
    Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oliceridine, a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic Model.
    Fossler MJ; Sadler BM; Farrell C; Burt DA; Pitsiu M; Skobieranda F; Soergel DG
    J Clin Pharmacol; 2018 Jun; 58(6):762-770. PubMed ID: 29393971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Characters of Oliceridine, a μ-Opioid Receptor G-Protein-Biased Ligand in Mice.
    Liang DY; Li WW; Nwaneshiudu C; Irvine KA; Clark JD
    Anesth Analg; 2019 Nov; 129(5):1414-1421. PubMed ID: 30044299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine and Hydromorphone Effects, Side Effects, and Variability: A Crossover Study in Human Volunteers.
    Meissner K; Dahan A; Olofsen E; Göpfert C; Blood J; Wieditz J; Kharasch ED
    Anesthesiology; 2023 Jul; 139(1):16-34. PubMed ID: 37014986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Effects of the Atypical Tricyclic Antidepressant Tianeptine in Human Models of Opioid-induced Respiratory Depression.
    Algera H; van der Schrier R; Cavalla D; van Velzen M; Roozekrans M; McMorn A; Snape M; Horrigan JP; Evans S; Kiernan B; Sarton E; Olofsen E; Niesters M; Dahan A
    Anesthesiology; 2022 Oct; 137(4):446-458. PubMed ID: 35867853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers.
    Romberg R; Olofsen E; Sarton E; Teppema L; Dahan A
    Anesthesiology; 2003 Oct; 99(4):788-98. PubMed ID: 14508308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic and Respiratory Depressant Effects of R-dihydroetorphine: A Pharmacokinetic-Pharmacodynamic Analysis in Healthy Male Volunteers.
    Olofsen E; Boom M; Sarton E; van Velzen M; Baily P; Smith KJ; Oksche A; Dahan A; Niesters M
    Anesthesiology; 2019 Dec; 131(6):1327-1339. PubMed ID: 31651529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion.
    Dahan A; Romberg R; Teppema L; Sarton E; Bijl H; Olofsen E
    Anesthesiology; 2004 Nov; 101(5):1201-9. PubMed ID: 15505457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esketamine counters opioid-induced respiratory depression.
    Jonkman K; van Rijnsoever E; Olofsen E; Aarts L; Sarton E; van Velzen M; Niesters M; Dahan A
    Br J Anaesth; 2018 May; 120(5):1117-1127. PubMed ID: 29661389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy.
    Viscusi ER; Skobieranda F; Soergel DG; Cook E; Burt DA; Singla N
    J Pain Res; 2019; 12():927-943. PubMed ID: 30881102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a nonsteroidal antiinflammatory drug (ketoprofen) on morphine respiratory depression: a double-blind, randomized study in volunteers.
    Moren J; Francois T; Blanloeil Y; Pinaud M
    Anesth Analg; 1997 Aug; 85(2):400-5. PubMed ID: 9249121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
    Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
    Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Ethanol on Oxycodone-induced Respiratory Depression: A Dose-escalating Study in Young and Elderly Individuals.
    van der Schrier R; Roozekrans M; Olofsen E; Aarts L; van Velzen M; de Jong M; Dahan A; Niesters M
    Anesthesiology; 2017 Mar; 126(3):534-542. PubMed ID: 28170358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
    Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
    Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.